![Matthew O'Connor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Matthew O'Connor is the founder of Cyclarity Therapeutics, Inc. He held the title of Chief Executive Officer-Scientific Affairs at the company.
Aktive Positionen von Matthew O'Connor
Unternehmen | Position | Beginn |
---|---|---|
Cyclarity Therapeutics, Inc.
![]() Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cyclarity Therapeutics, Inc.
![]() Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Commercial Services |